マーケットレポート詳細
分子診断の世界市場：製品・技術別、診断用途別2027年予測
Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年5月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文293ページになります。
- 商品コード：MAM2920
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
分子診断の世界市場規模は2022年で232億ドル、2027年に302億ドル、市場の平均年成長率は5.4%と予測されています。
レポートは分子診断の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品サービス別市場、テストタイプ別市場、等 ）を中心に構成されています。また競合状況、主要企業情報（10社）、市場ダイナミクス、COVID-19の影響分析、競合状況などの分析も加味し、分子診断市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆分子診断の世界市場予測2020-2027年
・市場規模(US$)
◆製品サービス別、市場-2027年
・試薬/キット
・装置
・サービス/ソフトウェア
※(市場規模US$)
◆テストタイプ別、市場-2027年
・LABテスト
・POCテスト
※(市場規模US$)
◆技術別、市場-2027年
・ポリメラーゼ連鎖反応 (PCR)
・等温核酸増幅技術 (INAAT)
・DNAシーケンシング/次世代シーケンシング (NGS)
・in situ ハイブリダイゼーション (ISH)
・DNAマイクロアレイ
・その他の技術
※(市場規模US$)
◆用途別、市場-2027年
感染症診断
・COVID-19
・肝炎
・HIV
・医療関連感染 (HAI)
・クラミジアトコチマス/淋病 (CT/NG)
・ヒトパピローマウイルス (HPV)
・結核
・インフルエンザ
・その他の感染症
腫瘍検査
・乳がん
・結腸がん/直腸がん
・肺がん
・前立腺がん
・その他がん
遺伝子検査
その他の用途
※(市場規模US$)
※感染症診断各種については、検査回数データ（million tests）も掲載
◆エンドユーザー別、市場-2027年
・診断検査室
・病院/クリニック
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、ロシア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※国地域別に製品サービス別、技術別、用途別、エンドユーザー別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・価格分析
・特許分析
・バリューチェーン分析
・サプライチェーン分析
・エコシステム/市場マップ
・ファイブフォース分析
・規制動向
・貿易分析
・技術分析
・ケーススタディ
・市場シェア分析
・競合状況
◆分子診断の主要企業プロフィール動向
・F. HOFFMANN-LA ROCHE LTD
・HOLOGIC, INC.
・PERKINELMER, INC.
・ABBOTT LABORATORIES
・THERMO FISHER SCIENTIFIC, INC.
・QIAGEN N.V
・SIEMENS HEALTHINEERS AG
・BIOMÉRIEUX SA
・MYRIAD GENETICS, INC.
・DANAHER CORPORATION
(その他企業)
・ILLUMINA, INC.
・GRIFOLS, S.A.
・QUIDEL CORPORATION
・AGILENT TECHNOLOGIES, INC
・DIASORIN S.P.A.
・EXACT SCIENCES CORPORATION
・GENETIC SIGNATURES
・MDXHEALTH
・HTG MOLECULAR DIAGNOSTICS, INC.
・BIOCARTIS NV
・TBG DIAGNOSTICS LIMITED
・VELA DIAGNOSTICS
・AMOY DIAGNOSTICS CO., LTD.
・ELITECHGROUP
・MOLBIO DIAGNOSTICS PVT. LTD.
・SAVYON DIAGNOSTICS
・ABACUS DIAGNOSTICA OY
・GENEOMBIO TECHNOLOGIES PVT. LTD.
（全293頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKETS COVERED
1.3.1 MOLECULAR DIAGNOSTICS MARKET
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
・ FIGURE 1... MOLECULAR DIAGNOSTICS MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY DATA
2.2.2.1 PRIMARY SOURCES
2.2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.3 KEY INDUSTRY INSIGHTS
2.2.2.4 BREAKDOWN OF PRIMARY INTERVIEWS
・ FIGURE 2................ BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 3................ BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・ FIGURE 4..... BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.3.1.3 GROWTH FORECAST
2.3.1.4 CAGR PROJECTIONS
・ FIGURE 5..... CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH. 50
・ FIGURE 6... MOLECULAR DIAGNOSTICS MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 7. DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RISK ASSESSMENT
2.9.1 RISK ASSESSMENT: MOLECULAR DIAGNOSTICS MARKET
3.... EXECUTIVE SUMMARY
・ FIGURE 8... MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION)
・ FIGURE 9... MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE,
2022 VS. 2027 (USD MILLION)
・ FIGURE 10. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION)
・ FIGURE 11. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)
・ FIGURE 12. MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)
・ FIGURE 13. MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2022 VS. 2027 (USD MILLION)
4.... PREMIUM INSIGHTS
4.1 MOLECULAR DIAGNOSTICS MARKET OVERVIEW
・ FIGURE 14.......... INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER IS EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
4.2 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027
・ FIGURE 15. REAGENTS & KITS WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE, 2022 VS. 2027
・ FIGURE 16......... THE LAB TESTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.4 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 VS. 2027
・ FIGURE 17... THE PCR SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING
THE FORECAST PERIOD
4.5 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2022 VS. 2027
・ FIGURE 18............... THE INFECTIOUS DISEASE DIAGNOSTICS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026
4.6 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027
・ FIGURE 19...... THE DIAGNOSTIC LABORATORIES SEGMENT TO CONTINUE TO DOMINATE
THE MARKET IN 2026
4.7 MOLECULAR DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 20........ ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 21. MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER
・ TABLE 1... ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER, 2020 VS. 2025
・ TABLE 2.......... GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025
5.2.1.2 RISING FOCUS ON R&D AND GROWING FUNDING IN MOLECULAR DIAGNOSTICS. 67
5.2.1.3 GROWING AWARENESS OF EARLY DISEASE DIAGNOSIS IN DEVELOPING COUNTRIES
5.2.1.4 RISING TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR DIAGNOSTICS
5.2.1.5 INCREASING USE OF POC DIAGNOSTIC TESTS
5.2.2 RESTRAINTS
5.2.2.1 UNFAVORABLE REIMBURSEMENT SCENARIO
5.2.2.2 HIGH COST OF INSTRUMENTS
5.2.3 OPPORTUNITIES
5.2.3.1 GROWING SIGNIFICANCE OF COMPANION DIAGNOSTICS
5.2.3.2 GROWTH OPPORTUNITIES IN EMERGING COUNTRIES
5.2.4 CHALLENGES
5.2.4.1 CHANGING REGULATORY LANDSCAPE
5.2.4.2 OPERATIONAL BARRIERS
5.2.4.3 INTRODUCTION OF ALTERNATIVE TECHNOLOGIES
5.2.5 IMPACT OF COVID-19 ON THE MOLECULAR DIAGNOSTICS MARKET
5.3 PRICING ANALYSIS
・ TABLE 3................ AVERAGE SELLING PRICE OF MOLECULAR DIAGNOSTIC PRODUCTS (2022)
5.4 PATENT ANALYSIS
・ FIGURE 22........... LIST OF MAJOR PATENTS FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
・ FIGURE 23........ VALUE CHAIN ANALYSIS OF THE MOLECULAR DIAGNOSTICS MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
・ FIGURE 24. MOLECULAR DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM/MARKET MAP
・ FIGURE 25. MOLECULAR DIAGNOSTICS MARKET: ECOSYSTEM/MARKET MAP
5.7.1 MOLECULAR DIAGNOSTICS MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4..... MOLECULAR DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT FROM NEW ENTRANTS
5.8.2 THREAT FROM SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 DEGREE OF COMPETITION
5.9 REGULATORY LANDSCAPE
・ TABLE 5.. NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 6...... ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 7... LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 8............... REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.1 NORTH AMERICA
5.9.1.1 US
5.9.1.2 CANADA
5.9.2 EUROPE
・ TABLE 9.. EUROPE: CLASSIFICATION OF DEVICES
5.9.3 ASIA PACIFIC
5.9.3.1 CHINA
5.9.3.2 JAPAN
5.9.3.3 INDIA
5.9.4 LATIN AMERICA
5.9.4.1 BRAZIL
5.9.4.2 MEXICO
5.9.5 MIDDLE EAST
5.9.6 AFRICA
5.10 TRADE ANALYSIS
5.10.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
5.10.1.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
5.10.1.2 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
5.11 TECHNOLOGY ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2022–2023
・ TABLE 10... MOLECULAR DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC. 89
・ FIGURE 26.. REVENUE SHIFT IN THE MOLECULAR DIAGNOSTICS MARKET
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS, BY END USER
・ FIGURE 27 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS, BY END USER
・ TABLE 11. INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS, BY END USER (%)
5.14.2 BUYING CRITERIA
・ FIGURE 28.. KEY BUYING CRITERIA, BY END USER
・ TABLE 12.... KEY BUYING CRITERIA, BY END USER
5.15 CASE STUDIES
・ FIGURE 29. CASE STUDY: MARKET ASSESSMENT AND CONSUMER BUYING BEHAVIOR IN INDIA
6.... MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
・ TABLE 13... MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 14... PRICES OF MOLECULAR DIAGNOSTIC PRODUCTS (2021)
6.2 REAGENTS & KITS
6.2.1 RECURRENT PURCHASES OF REAGENTS & KITS—A KEY FACTOR PROPELLING MARKET GROWTH
・ TABLE 15 MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION,
2020–2027 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 INCREASING NEED FOR FASTER & MORE ACCURATE TEST RESULTS TO BOOST THE DEMAND FOR MOLECULAR DIAGNOSTIC INSTRUMENTS
・ TABLE 16.. KEY INSTRUMENTS AVAILABLE IN THE MARKET
・ TABLE 17................. MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2020–2027 (USD MILLION)
6.4 SERVICES & SOFTWARE
6.4.1 GROWING UPTAKE OF ADVANCED INSTRUMENTS IN THE MOLECULAR DIAGNOSTICS MARKET TO DRIVE GROWTH IN THIS MARKET SEGMENT
・ TABLE 18. MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
7.... MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE
7.1 INTRODUCTION
・ TABLE 19... MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2027 (USD MILLION)
7.2 LAB TESTS
7.2.1 HIGH BURDEN OF COVID-19 TO DRIVE MARKET GROWTH
・ TABLE 20.... MOLECULAR DIAGNOSTICS MARKET FOR LAB TESTS, BY REGION,
2020–2027 (USD MILLION)
7.3 POC TESTS
7.3.1 INCREASING ADOPTION OF POC TECHNOLOGIES TO DRIVE SEGMENTAL GROWTH IN THE COMING YEARS
・ TABLE 21.... MOLECULAR DIAGNOSTICS MARKET FOR POC TESTS, BY REGION,
2020–2027 (USD MILLION)
8.... MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.1.1 PRIMARY NOTES
8.1.1.1 KEY INDUSTRY INSIGHTS
・ TABLE 22... MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
8.2 POLYMERASE CHAIN REACTION (PCR)
8.2.1 GROWING USE OF PCR IN PROTEOMICS AND GENOMICS MAKES THIS THE LARGEST MARKET SEGMENT
・ TABLE 23.... MOLECULAR DIAGNOSTICS MARKET FOR POLYMERASE CHAIN REACTION,
BY REGION, 2020–2027 (USD MILLION)
8.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
8.3.1 COST BENEFITS OF INAAT TO DRIVE MARKET GROWTH
・ TABLE 24.... MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2020–2027 (USD MILLION)
8.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING
8.4.1 INCREASING USE OF NGS IN CANCER DIAGNOSIS TO FUEL GROWTH IN THIS MARKET SEGMENT
・ TABLE 25.... MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2020–2027 (USD MILLION)
8.5 IN SITU HYBRIDIZATION (ISH)
8.5.1 RISING PREVALENCE OF CANCER AND GENETIC DISORDERS— A KEY FACTOR DRIVING GROWTH
・ TABLE 26.... MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY REGION, 2020–2027 (USD MILLION)
8.6 DNA MICROARRAYS
8.6.1 INTRODUCTION OF DNA MICROARRAYS HAS ACCELERATED GENE EXPRESSION AND DISEASE DIAGNOSIS
・ TABLE 27.... MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAYS, BY REGION, 2020–2027 (USD MILLION)
8.7 OTHER TECHNOLOGIES
・ TABLE 28.... MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2020–2027 (USD MILLION)
9.... MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
9.1 INTRODUCTION
・ TABLE 29... MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
9.2 INFECTIOUS DISEASE DIAGNOSTICS
・ TABLE 30.... MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 31.... MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
9.2.1 COVID-19
9.2.1.1 GROWING BURDEN OF COVID-19 IS A KEY FACTOR DRIVING MARKET GROWTH. 114
・ TABLE 32... DISTRIBUTION OF TOTAL NUMBER OF CASES, BY COUNTRY
・ TABLE 33.... MOLECULAR DIAGNOSTICS MARKET FOR COVID-19 TESTING, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 34.... MOLECULAR DIAGNOSTICS MARKET FOR COVID-19 TESTING, BY REGION, 2020–2027 (MILLION TESTS) 115
9.2.2 HEPATITIS
9.2.2.1 INCREASING ADOPTION OF ADVANCED TECHNOLOGIES FOR THE DIAGNOSIS OF HEPATITIS B TO DRIVE GROWTH IN THIS SEGMENT
・ TABLE 35.... MOLECULAR DIAGNOSTICS MARKET FOR HEPATITIS TESTING, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 36.... MOLECULAR DIAGNOSTICS MARKET FOR HEPATITIS TESTING, BY REGION, 2020–2027 (MILLION TESTS) 116
9.2.3 HIV
9.2.3.1 HIGH GLOBAL PREVALENCE OF HIV WILL DRIVE THE NEED FOR MOLECULAR DIAGNOSTIC TESTS
・ TABLE 37.... MOLECULAR DIAGNOSTICS MARKET FOR HIV TESTING, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 38.... MOLECULAR DIAGNOSTICS MARKET FOR HIV TESTING, BY REGION,
2020–2027 (MILLION TESTS)
9.2.4 HAI
9.2.4.1 RISING BURDEN OF MRSA INFECTIONS AND THE INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED HAI DIAGNOSTIC TESTS WILL LIKELY DRIVE MARKET GROWTH
・ TABLE 39.... MOLECULAR DIAGNOSTICS MARKET FOR HAI TESTING, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 40.... MOLECULAR DIAGNOSTICS MARKET FOR HAI TESTING, BY REGION,
2020–2027 (MILLION TESTS)
9.2.5 CT/NG
9.2.5.1 CT/NG INFECTIONS ARE THE MOST COMMON STDS WORLDWIDE—A KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 41.... MOLECULAR DIAGNOSTICS MARKET FOR CT/NG TESTING, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 42.... MOLECULAR DIAGNOSTICS MARKET FOR CT/NG TESTING, BY REGION, 2020–2027 (MILLION TESTS)
9.2.6 HPV
9.2.6.1 TECHNOLOGICAL ADVANCEMENTS SUCH AS RAPID HPV DIAGNOSTICS DRIVE GROWTH IN THIS SEGMENT
・ TABLE 43.... MOLECULAR DIAGNOSTICS MARKET FOR HPV TESTING, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 44.... MOLECULAR DIAGNOSTICS MARKET FOR HPV TESTING, BY REGION,
2020–2027 (MILLION TESTS)
9.2.7 TUBERCULOSIS
9.2.7.1 INCREASING BURDEN OF TB GLOBALLY TO PROPEL THE DEMAND FOR MDX TESTS. 122
・ TABLE 45.... MOLECULAR DIAGNOSTICS MARKET FOR TUBERCULOSIS TESTING,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 46.... MOLECULAR DIAGNOSTICS MARKET FOR TUBERCULOSIS TESTING,
BY REGION, 2020–2027 (MILLION TESTS)
9.2.8 INFLUENZA
9.2.8.1 RISING FOCUS ON CONTAINING THE SPREAD OF INFLUENZA TO PROPEL GROWTH IN THIS SEGMENT
・ TABLE 47.... MOLECULAR DIAGNOSTICS MARKET FOR INFLUENZA TESTING, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 48.... MOLECULAR DIAGNOSTICS MARKET FOR INFLUENZA TESTING, BY REGION, 2020–2027 (MILLION TESTS) 124
9.2.9 OTHER INFECTIOUS DISEASES
・ TABLE 49.... MOLECULAR DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASES,
BY REGION, 2020–2027 (USD MILLION)
9.3 ONCOLOGY TESTING
・ TABLE 50.... MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 51.... MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
9.3.1 BREAST CANCER
9.3.1.1 INCREASING PREVALENCE OF BREAST CANCER IS A KEY DRIVER FOR MARKET GROWTH
・ TABLE 52......... BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040
・ TABLE 53 MOLECULAR DIAGNOSTIC MARKET FOR BREAST CANCER, BY REGION, 2020–2027 (USD MILLION)
9.3.2 COLORECTAL CANCER. 128
9.3.2.1 RISING FOCUS ON THE DEVELOPMENT OF COMPANION DIAGNOSTIC ASSAYS FOR COLORECTAL CANCER DRIVES MARKET GROWTH
・ TABLE 54.... MOLECULAR DIAGNOSTICS MARKET FOR COLORECTAL CANCER, BY REGION, 2020–2027 (USD MILLION)
9.3.3 LUNG CANCER
9.3.3.1 INCREASING RESEARCH FOR LUNG CANCER BIOMARKERS TO DRIVE MARKET GROWTH
・ TABLE 55.... MOLECULAR DIAGNOSTICS MARKET FOR LUNG CANCER, BY REGION,
2020–2027 (USD MILLION)
9.3.4 PROSTATE CANCER. 129
9.3.4.1 ADVANCEMENTS IN GENOMIC TECHNOLOGIES FOR THE DEVELOPMENT OF NEW BIOMARKERS WILL DRIVE THE MARKET GROWTH
・ TABLE 56.... MOLECULAR DIAGNOSTICS MARKET FOR PROSTATE CANCER, BY REGION, 2020–2027 (USD MILLION)
9.3.5 OTHER CANCERS
・ TABLE 57.... GLOBAL CANCER INCIDENCE, 2020
・ TABLE 58.... MOLECULAR DIAGNOSTICS MARKET FOR OTHER CANCERS, BY REGION, 2020–2027 (USD MILLION)
9.4 GENETIC TESTING
9.4.1 GENETIC TESTING ENABLES THE DIAGNOSIS OF VARIOUS DISEASES—A KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 59.... MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 131
9.5 OTHER APPLICATIONS
・ TABLE 60.... MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
10.. MOLECULAR DIAGNOSTICS MARKET, BY END USER
10.1 INTRODUCTION
・ TABLE 61... MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
10.2 DIAGNOSTIC LABORATORIES
10.2.1 INCREASING OUTSOURCING OF ACTIVITIES TO DIAGNOSTIC LABORATORIES FOR REDUCED COSTS TO DRIVE MARKET GROWTH
・ TABLE 62.... MOLECULAR DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2020–2027 (USD MILLION)
10.3 HOSPITALS & CLINICS
10.3.1 INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE THE GROWTH OF THIS SEGMENT
・ TABLE 63.... MOLECULAR DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
10.4 OTHER END USERS
・ TABLE 64.... MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
11.. MOLECULAR DIAGNOSTICS MARKET, BY REGION
11.1 INTRODUCTION
・ TABLE 65... MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2020–2027 (USD MILLION)
11.2 NORTH AMERICA
・ FIGURE 30......... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 66........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 67........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 68........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・ TABLE 69........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 70........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 71........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 72........... NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.1 US
11.2.1.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE MARKET GROWTH IN THE US
・ TABLE 73.......... US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 74.......... US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 75.......... US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 76.......... US: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 77.......... US: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 78.......... US: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.2.2 CANADA
11.2.2.1 AVAILABILITY OF FUNDING FOR GENOMICS RESEARCH MAKES CANADA A SIZEABLE MARKET FOR MOLECULAR DIAGNOSTICS
・ TABLE 79... CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 80... CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 81... CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 82... CANADA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 83... CANADA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 84... CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3 EUROPE
・ TABLE 85... EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 86... EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 87... EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 88... EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 89... EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 90... EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 91... EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN GERMANY. 156
・ TABLE 92. GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 93. GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 94. GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 95. GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 96. GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 97. GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.2 UK
11.3.2.1 GROWING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES PROPELS MARKET GROWTH FOR MOLECULAR DIAGNOSTICS IN THE UK
・ TABLE 98.......... UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 99.......... UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 100........ UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 101........ UK: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 102........ UK: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 103........ UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 RISING R&D EXPENDITURE IN FRANCE TO DRIVE MARKET GROWTH
・ TABLE 104.. FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 105.. FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 106.. FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 107.. FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 108.. FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 109.. FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.4 ITALY
11.3.4.1 ADOPTION OF ADVANCED DIAGNOSTIC TECHNOLOGIES TO DRIVE MARKET GROWTH IN ITALY. 165
・ TABLE 110..... ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 111..... ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 112..... ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 113..... ITALY: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 114..... ITALY: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 115..... ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.5 RUSSIA
11.3.5.1 INCREASING ACCESS TO QUALITY HEALTHCARE WILL SUPPORT MARKET GROWTH IN RUSSIA
・ TABLE 116.. RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 117.. RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 118.. RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 119.. RUSSIA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 120.. RUSSIA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 121.. RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 GROWING DEMAND FOR GENETIC TESTING IN SPAIN TO CREATE MAJOR GROWTH OPPORTUNITIES FOR MARKET PLAYERS
・ TABLE 122.... SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 123.... SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 124.... SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 125.... SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 126.... SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 127.... SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.3.7 REST OF EUROPE
・ TABLE 128....... ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 129....... ROE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 130....... ROE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 131....... ROE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 132....... ROE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 133....... ROE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.4 ASIA PACIFIC
・ FIGURE 31..... APAC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 134..... APAC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 135..... APAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 136..... APAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 137..... APAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 138..... APAC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 139..... APAC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 140..... APAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.4.1 CHINA
11.4.1.1 GROWING PUBLIC ACCESS TO MODERN HEALTHCARE AND THE OUTBREAK OF COVID-19 TO DRIVE MARKET GROWTH
・ TABLE 141.... CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 142.... CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 143.... CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 144.... CHINA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 145.... CHINA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 146.... CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 UNIVERSAL HEALTHCARE REIMBURSEMENT POLICY TO DRIVE MARKET GROWTH IN JAPAN
・ TABLE 147.... JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 148.... JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 149.... JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 150.... JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 151.... JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 152.... JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.4.3 INDIA
11.4.3.1 INCREASING PRIVATE & PUBLIC INVESTMENTS IN THE COUNTRY’S HEALTHCARE SYSTEM WILL DRIVE MARKET GROWTH
・ TABLE 153..... INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)
・ TABLE 154..... INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 155..... INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 156..... INDIA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 157..... INDIA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 158..... INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 HIGH PREVALENCE OF INFECTIOUS DISEASES MAKES AUSTRALIA A RELATIVELY LARGE MARKET IN THE APAC
・ TABLE 159................ AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 160................ AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 161................ AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 162................ AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 163................ AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION) 194
・ TABLE 164................ AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
・ TABLE 165. ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 166. ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 167. ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 168. ROAPAC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 169. ROAPAC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 170. ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.5 LATIN AMERICA
・ TABLE 171........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 172........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 173........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・ TABLE 174........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 175........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 176........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 177........... LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE THE GROWTH OF
THE MOLECULAR DIAGNOSTICS MARKET IN BRAZIL
・ TABLE 178... BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 179... BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 180... BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 181... BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 182... BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 183... BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 IMPROVING ACCESSIBILITY AND AFFORDABILITY OF HEALTHCARE SERVICES IN MEXICO MAKES IT A FAVORABLE MARKET FOR MOLECULAR DIAGNOSTICS
・ TABLE 184.. MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 185.. MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 186.. MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 187.. MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 188.. MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 189.. MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
・ TABLE 190 ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 191 ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)
・ TABLE 192 ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 193 ROLATAM: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 194 ROLATAM: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 195 ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
・ TABLE 196 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
・ TABLE 197 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION)
・ TABLE 198 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 199 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC APPLICATIONS, BY TYPE,
2020–2027 (USD MILLION)
・ TABLE 200 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 201 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
12.. COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE MOLECULAR DIAGNOSTICS MARKET
・ TABLE 202 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MOLECULAR DIAGNOSTIC MANUFACTURING COMPANIES
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・ FIGURE 32.... REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE MOLECULAR DIAGNOSTICS MARKET
12.4 MARKET SHARE ANALYSIS
12.4.1 MOLECULAR DIAGNOSTICS MARKET
・ FIGURE 33.. MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER (2021)
・ TABLE 203. MOLECULAR DIAGNOSTICS MARKET: DEGREE OF COMPETITION
12.4.2 MOLECULAR DIAGNOSTICS MARKET SHARE & RANKING ANALYSIS,
BY TECHNOLOGY
12.4.2.1 POLYMERASE CHAIN REACTION (PCR)
・ FIGURE 34.. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE FOR PCR,
BY KEY PLAYER (2021)
12.4.2.2 DNA SEQUENCING AND NGS
・ FIGURE 35.. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE FOR DNA SEQUENCING & NGS, BY KEY PLAYER (2021)
12.4.2.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
・ TABLE 204.. GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR INAAT,
BY KEY PLAYER, 2021
12.4.2.4 IN SITU HYBRIDIZATION (ISH)
・ TABLE 205.. GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR ISH,
BY KEY PLAYER, 2021
12.4.3 MOLECULAR DIAGNOSTICS MARKET RANKING ANALYSIS, BY APPLICATION
12.4.3.1 INFECTIOUS DISEASES
・ TABLE 206.. GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR INFECTIOUS DISEASES, BY KEY PLAYER, 2021
12.4.3.2 COVID-19
・ TABLE 207.. GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR COVID-19,
BY KEY PLAYER, 2021
12.5 COMPANY EVALUATION QUADRANT
12.5.1 LIST OF EVALUATED VENDORS
12.5.2 STARS
12.5.3 EMERGING LEADERS
12.5.4 PERVASIVE PLAYERS
12.5.5 PARTICIPANTS
・ FIGURE 36. MOLECULAR DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
12.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
・ FIGURE 37. MOLECULAR DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
12.7 COMPETITIVE BENCHMARKING
12.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
・ FIGURE 38............ PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE MOLECULAR DIAGNOSTICS MARKET
・ TABLE 208. MOLECULAR DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
・ TABLE 209....... COMPANY PRODUCT & SERVICE FOOTPRINT
・ TABLE 210...... COMPANY REGIONAL FOOTPRINT
・ TABLE 211. MOLECULAR DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
12.8 COMPETITIVE SCENARIO.. 228
12.8.1 PRODUCT LAUNCHES
・ TABLE 212............. KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
12.8.2 DEALS
・ TABLE 213.................................. KEY DEALS
13.. COMPANY PROFILES
13.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS)*
13.1.1 F. HOFFMANN-LA ROCHE LTD
・ TABLE 214......... F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・ FIGURE 39......... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
13.1.2 HOLOGIC, INC.
・ TABLE 215 HOLOGIC, INC.: BUSINESS OVERVIEW
・ FIGURE 40 HOLOGIC, INC.: COMPANY SNAPSHOT (2021)
13.1.3 PERKINELMER, INC.
・ TABLE 216........ PERKINELMER, INC.: BUSINESS OVERVIEW
・ FIGURE 41........ PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
13.1.4 ABBOTT LABORATORIES
・ TABLE 217... ABBOTT LABORATORIES: BUSINESS OVERVIEW
・ FIGURE 42... ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
13.1.5 THERMO FISHER SCIENTIFIC, INC.
・ TABLE 218.... THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
・ FIGURE 43.... THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
13.1.6 QIAGEN N.V.
・ TABLE 219... QIAGEN N.V.: BUSINESS OVERVIEW
・ FIGURE 44... QIAGEN N.V.: COMPANY SNAPSHOT (2021)
13.1.7 SIEMENS HEALTHINEERS AG
・ TABLE 220........... SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
・ FIGURE 45........... SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
13.1.8 BIOMÉRIEUX SA
・ TABLE 221............. BIOMÉRIEUX SA: BUSINESS OVERVIEW
・ FIGURE 46............. BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
13.1.9 MYRIAD GENETICS, INC.
・ TABLE 222... MYRIAD GENETICS, INC.: BUSINESS OVERVIEW
・ FIGURE 47... MYRIAD GENETICS, INC.: COMPANY SNAPSHOT (2021)
13.1.10 DANAHER CORPORATION
・ TABLE 223. DANAHER CORPORATION: BUSINESS OVERVIEW
・ FIGURE 48. DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
*BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.2 OTHER PLAYERS
13.2.1 ILLUMINA, INC.
・ TABLE 224 ILLUMINA, INC.: COMPANY OVERVIEW
13.2.2 BECTON, DICKINSON AND COMPANY
・ TABLE 225. BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
13.2.3 GRIFOLS, S.A.
・ TABLE 226. GRIFOLS, S.A.: COMPANY OVERVIEW
13.2.4 QUIDEL CORPORATION
・ TABLE 227..... QUIDEL CORPORATION: COMPANY OVERVIEW
13.2.5 AGILENT TECHNOLOGIES, INC. 279
・ TABLE 228......... AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
13.2.6 DIASORIN S.P.A.
・ TABLE 229............. DIASORIN S.P.A.: COMPANY OVERVIEW
13.2.7 EXACT SCIENCES CORPORATION.. 282
・ TABLE 230...... EXACT SCIENCES CORPORATION: COMPANY OVERVIEW
13.2.8 GENETIC SIGNATURES
・ TABLE 231..... GENETIC SIGNATURES: COMPANY OVERVIEW
13.2.9 MDXHEALTH
・ TABLE 232.... MDXHEALTH: COMPANY OVERVIEW
13.2.10 HTG MOLECULAR DIAGNOSTICS, INC.
・ TABLE 233 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY OVERVIEW
13.2.11 BIOCARTIS NV
・ TABLE 234. BIOCARTIS NV: COMPANY OVERVIEW
13.2.12 TBG DIAGNOSTICS LIMITED
・ TABLE 235............. TBG DIAGNOSTICS LIMITED: COMPANY OVERVIEW
13.2.13 VELA DIAGNOSTICS
・ TABLE 236......... VELA DIAGNOSTICS: COMPANY OVERVIEW
13.2.14 AMOY DIAGNOSTICS CO., LTD. 288
・ TABLE 237......... AMOY DIAGNOSTICS CO., LTD.: COMPANY OVERVIEW
13.2.15 ELITECHGROUP
・ TABLE 238 ELITECHGROUP: COMPANY OVERVIEW
13.2.16 MOLBIO DIAGNOSTICS PVT. LTD. 290
・ TABLE 239...... MOLBIO DIAGNOSTICS PVT. LTD.: COMPANY OVERVIEW
13.2.17 SAVYON DIAGNOSTICS
・ TABLE 240..... SAVYON DIAGNOSTICS: COMPANY OVERVIEW
13.2.18 ABACUS DIAGNOSTICA OY
・ TABLE 241 ABACUS DIAGNOSTICA OY.: COMPANY OVERVIEW
13.2.19 GENEOMBIO TECHNOLOGIES PVT. LTD.
・ TABLE 242..... GENEOMBIO TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW